CRISPR

Patented CRISPRclean™ technology is a foundational tool that improves the performance of next-generation sequencing and other molecular workflows by increasing sensitivity, reducing costs, and enabling novel discovery

ERS Genomics holds an exclusive worldwide license from Dr. Charpentier to the foundational patents covering CRISPR/Cas9

The new CRISPR-guided DNA base editing technologies are designed to efficiently induce "transversion" alterations of DNA bases while minimizing levels of unwanted "bystander" mutation

New platform will enable long-term tracking of cardiomyocytes produced from induced pluripotent stem cells after implantation into the heart

Results of recent experiments are likely to speed up and aid understanding of the DNA activity that typically causes aging and many cancers

The kit works by programming a CRISPR molecule to detect the presence of the genetic signature for SARS-CoV-2

The diagnostic platform CARMEN combines microfluidics with the CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts

Study shows, for the first time, that whole genome CRISPR-based screens can be carried out in a manner that is much more physiologically relevant, researcher says

Rapid and early detection of SARS-CoV-2 plays a crucial role in facilitating early intervention and treatment and preventing disease spread

A timeline of the CRISPR/Cas system, from the identification of a distinct repetitive sequence to its use in gene editing and beyond